IBD Plexus Publications
06/26/2023
SPARC IBD
Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis
Inflammatory Bowel Disease
Manuscript06/19/2023
SPARC IBD
Uncovering genetic mechanisms of inflammatory bowel disease through DNA-RNA integration analyses of the inflamed colon tissue
European Human Genetics Conference
Abstract/Poster06/16/2023
SPARC IBD
Yield of Serial Testing for Tuberculosis Exposure in Patients With Inflammatory Bowel Diseases: One Test is Not Enough
Clinical Gastroenterology and Hepatology
Manuscript05/29/2023
IBD Partners
Results from the COMPARE Study – How Do Different Medications Impact IBD Patients? Ulcerative Colitis
Crohn's & Colitis 360
Manuscript05/29/2023
SPARC IBD
Comparing Patient Reported Outcomes among Anti-TNF Experienced Patients with Ulcerative Colitis Initiating Vedolizumab versus Tofacitinib
Crohn's & Colitis 360
Manuscript05/23/2023
SPARC IBD
Alterations in the Fungal Microbiome in Ulcerative Colitis
Inflammatory Bowel Diseases
Manuscript05/09/2023
SPARC IBD
Sex-based Differences in Drug Durability Among Patients with Inflammatory Bowel Diseases
Digestive Diseases Week (DDW)
Abstract/Poster05/09/2023
SPARC IBD
Sex-based Differences in Clinical and Endoscopic Outcomes Among Patients with Inflammatory Bowel Diseases
Digestive Diseases Week (DDW)
Abstract/Poster05/09/2023
SPARC IBD
Blood-based DNA Methylation Biomarkers to Distinguish Irritable Bowel Syndrome, Inflammatory Bowel Disease and Celiac Disease
Digestive Diseases Week (DDW)
Abstract/Poster